Kyle Mikson
Stock Analyst at Canaccord Genuity
(3.60)
# 848
Out of 5,138 analysts
120
Total ratings
46.24%
Success rate
8.38%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WGS GeneDx Holdings | Maintains: Buy | $160 → $170 | $109.28 | +55.56% | 3 | Dec 22, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $19 → $20 | $21.20 | -5.66% | 10 | Dec 22, 2025 | |
| TEM Tempus AI | Maintains: Buy | $95 → $80 | $68.92 | +16.08% | 3 | Dec 22, 2025 | |
| QTRX Quanterix | Maintains: Hold | $5 → $8 | $7.95 | +0.63% | 8 | Dec 22, 2025 | |
| QSI Quantum-Si incorporated | Maintains: Hold | $2 → $1.5 | $1.23 | +21.95% | 6 | Dec 22, 2025 | |
| NTRA Natera | Maintains: Buy | $250 → $285 | $240.34 | +18.58% | 12 | Dec 22, 2025 | |
| ILMN Illumina | Maintains: Hold | $112 → $130 | $145.30 | -10.53% | 14 | Dec 22, 2025 | |
| GH Guardant Health | Maintains: Buy | $100 → $125 | $111.98 | +11.63% | 10 | Dec 22, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $37 → $50 | $40.75 | +22.70% | 6 | Dec 22, 2025 | |
| CAI Caris Life Sciences | Maintains: Hold | $28 → $30 | $27.12 | +10.62% | 2 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $85 → $105 | $102.34 | +2.60% | 10 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $105 | $97.44 | +7.76% | 5 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $40 → $43 | $41.00 | +4.88% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $150 → $165 | $161.69 | +2.05% | 4 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $15 | $4.83 | +210.56% | 5 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $20 | $8.33 | +140.10% | 5 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $2.35 | +27.66% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.25 | +140.00% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.29 | +585.87% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $1,476 | $8.75 | +16,768.57% | 1 | Mar 30, 2021 |
GeneDx Holdings
Dec 22, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $109.28
Upside: +55.56%
10x Genomics
Dec 22, 2025
Maintains: Buy
Price Target: $19 → $20
Current: $21.20
Upside: -5.66%
Tempus AI
Dec 22, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $68.92
Upside: +16.08%
Quanterix
Dec 22, 2025
Maintains: Hold
Price Target: $5 → $8
Current: $7.95
Upside: +0.63%
Quantum-Si incorporated
Dec 22, 2025
Maintains: Hold
Price Target: $2 → $1.5
Current: $1.23
Upside: +21.95%
Natera
Dec 22, 2025
Maintains: Buy
Price Target: $250 → $285
Current: $240.34
Upside: +18.58%
Illumina
Dec 22, 2025
Maintains: Hold
Price Target: $112 → $130
Current: $145.30
Upside: -10.53%
Guardant Health
Dec 22, 2025
Maintains: Buy
Price Target: $100 → $125
Current: $111.98
Upside: +11.63%
Castle Biosciences
Dec 22, 2025
Maintains: Buy
Price Target: $37 → $50
Current: $40.75
Upside: +22.70%
Caris Life Sciences
Dec 22, 2025
Maintains: Hold
Price Target: $28 → $30
Current: $27.12
Upside: +10.62%
Nov 25, 2025
Downgrades: Hold
Price Target: $85 → $105
Current: $102.34
Upside: +2.60%
Nov 17, 2025
Maintains: Buy
Price Target: $85 → $105
Current: $97.44
Upside: +7.76%
Nov 5, 2025
Maintains: Hold
Price Target: $40 → $43
Current: $41.00
Upside: +4.88%
Oct 29, 2025
Maintains: Hold
Price Target: $150 → $165
Current: $161.69
Upside: +2.05%
Oct 27, 2025
Maintains: Buy
Price Target: $11 → $15
Current: $4.83
Upside: +210.56%
Sep 19, 2025
Maintains: Buy
Price Target: $30 → $20
Current: $8.33
Upside: +140.10%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $2.35
Upside: +27.66%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.25
Upside: +140.00%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.29
Upside: +585.87%
Mar 30, 2021
Initiates: Overweight
Price Target: $1,476
Current: $8.75
Upside: +16,768.57%